Top compounds associated with response to TUFM


Feature Type Standardized
Nominal ANOVA
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.03
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.03
mRNA COL-3 CTRPv2 pan-cancer AAC 0.082 0.03
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.071 0.03
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.083 0.03
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.077 0.03
mRNA VX-702 GDSC1000 pan-cancer AAC 0.077 0.03
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.08 0.03
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.095 0.03
mRNA SID 26681509 CTRPv2 pan-cancer AAC -0.082 0.03
Download CSV